<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1101</article-id><article-id pub-id-type="doi">10.36691/RJA1101</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">PROTIVOALLERGIChESKIE SVOYSTVAEKSTRAKTOV OVSA RHEALBA</article-title><trans-title-group xml:lang="ru"><trans-title>ПРОТИВОАЛЛЕРГИЧЕСКИЕ СВОЙСТВАЭКСТРАКТОВ ОВСА RHEALBA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gushchin</surname><given-names>I S</given-names></name><name xml:lang="ru"><surname>Гущин</surname><given-names>И С</given-names></name></name-alternatives><bio xml:lang="ru"><p>ГНЦ «Институт иммунологии ФМБА России», Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГНЦ «Институт иммунологии ФМБА России», Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2008-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2008</year></pub-date><volume>5</volume><issue>1</issue><issue-title xml:lang="en">NO1 (2008)</issue-title><issue-title xml:lang="ru">№1 (2008)</issue-title><fpage>5</fpage><lpage>11</lpage><history><date date-type="received" iso-8601-date="2020-03-11"><day>11</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2008, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2008, Фармарус Принт Медиа</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2010-03-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/1101">https://rusalljournal.ru/raj/article/view/1101</self-uri><abstract xml:lang="ru"><p>Данные, полученные на клеточных фармакологических моделях, свидетельствуют о том, что полифе-
нольные экстракты овса Rhealba обладают противовоспалительным действием на важные патофизио-
логические звенья, вовлекаемые в патогенез атопического дерматита. Эти экстракты восстанавливают
функцию эпидермального барьера и ликвидируют сухость кожи, что ведет к уменьшению кожного зуда,
расчесывания и риска инфицирования. Использование экстрактов овса в клинических условиях подав-
ляет проявления атопического дерматита, включая зуд и расчесы. Клинические испытания показыва-
ют, что мягчительные средства, содержащие экстракт овса Rhealba, являются высокоэффективными
стероид-замещающими агентами и рассматриваются как средства первой линии при ведении больных
атопическим дерматитом, настоятельно рекомендуемые международными и национальными согласи-
тельными документами и руководствами.</p></abstract><kwd-group xml:lang="ru"><kwd>экстракты овса</kwd><kwd>овес Rhealba</kwd><kwd>противоаллергическое действие</kwd><kwd>атопический дерматит</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Czerwinski J., Bartnikowska E., Leontowicz H. et al. Oat (Avena sativa L.) and amaranth (Amaranthus hypochondriacus) meals positively affect plasma lipid profile in rats cholesterol-containing diets. J. Nutr. Biochem. 2004, v. 15, p. 622-629.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Reyna-Villasmil N., Bermudez-Pirela V., Mengual-Moreno E. et al. Oat-derived beta-glucan significantly improves HDLC and diminishes LDCL and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia. Am. J. Ther. 2007, v. 14, p.203-212.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Davis J.M., Murphy E.A., Brown A.S. et al. Effects of oat beta-glucan on innate immunity and infection after exercise stress. Med. Sci. Sports Exerc. 2004, v. 36, p. 1321-1327.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Murphy E.A., Davis J.M., Brown A.S. et al. Oat beta-glucan effects on neutrophyl respiratory burst activity following exercise. Med. Sci. Sports Exerc. 2007, v. 39, p. 639-644</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Murphy E.A., Davis J.M., Brown A.S. et al. Effects of moderate exercise and oat beta-glucan on lung tumor metastases and macrophage antitumor cytotoxicity. J. Appl. Physiol. 2004, v. 97, p. 955-959.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kurtz E.S., Wallo W. Colloidal oatmeal: history, chemistry and clinical properties. J. Drugs Dermatol. 2007, v. 6, p. 176-170.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wu J. Treatment of rosacea with herbal ingredients. J. Drugs Dermatol. 2006, v. 5, p. 29-32.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Rothe M.J., Bernstein M.L., Grant-kels J.M. Life-threatening erythroderma: diagnosing and treating the «red man». Clin. Dermatol. 2005, v. 23, p. 206-217.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Matheson J.D., Clayton J., Muller M.J. The reduction of itch during burn wound healing. J. Burn Care Rehabil. 2001, v. 22, p. 76-81.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Alexandrescu D.T., Vaillant J.G., Dasanu C.A. Effect of treatment with colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine-kinase inhibitors. Clin. Exp. Dermatol. 2007, v. 32, p. 71-74</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Polyphenolic extract of Rhealba oat. A new advance in dermo-cosmetics. Scientific file. Ducray Laboratories Dermatologiques. 2005, 24 p.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Martty J.-P. The pharmacological properties of Rhealba oat. Satellite Symposium - World Congress. Safety and efficacy of Avena Rhealba in dermatology. Paris, 2002, p. 6-8.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Vie K., Cours-Darne S., Vienne M.P. et al. Modulating effects of oatmeals extracts in the sodium lauryl sulfate skin irritancy model. Skin Pharmacol. Appl. Skin Physiol. 2002, v. 15, p. 120-124</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Boisnic S., Branchet-Gumila M.C., Coutanceau C. Inhibitory effect of oatmeal extract oligomer on vasoactive intеstinal peptide-induced inflammation in surviving human skin. Int. J. Tissue React. 2003, v. 25, p. 41-46</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Aries M.-F., Vaissiere C., Pinelli E. et al. Avena Rhealba inhibits A23187-stimulated arachidonic acid mobilization, eicosanoid release, and cPLA2 expression in human keratinocytes: potential in cutaneous inflammatory disorders. Biol. Pharm. Bull. 2005, v. 28, p. 601-606.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Bovicelli P. Radical-scavenging polyphenols: new strategies for their synthesis. J. Pharm. Pharmacol. 2007, v. 59, p. 1703-1710.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Boisnic S., Brabchet M.C., Ermosilla V. Healing effect of spray containing Rhealba oat colloidal extract in an in vitro reconstitution model of skin. Int. J. Tissue React. 2005, v. 27, p. 83-89.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Aries M.F., Vaissiere C., Charveron M. Anti-inflammatory and immunomodulatory activity of Avena Rhealba oatmeal - polyphenolic extraxt: interest in skin inflammatory disorders as atopic dermatitis pathology. J. Invest. Dermatol. 2005, v. 124 (suppl 1), p. A7.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Гущин И.С. Эпидермальный барьер и аллергия. Рос. аллергол. журн. 2007, № 2, с. 3-16.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Российский национальный согласительный документ по атопическому дерматиту. Под ред. Р.М. Хаитова, А.А.Кубановой. М., «Фармарус Принт», 2002.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Darsow U., Lubbe J., Taieb A. et al. European task force on atopic dermatitis. J. Eur. Acad. Dermatol. Venerol. 2005, v. 19, p. 286-295.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Grimalt R., Mengeaud V., Cambazard F. The study investigators' group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology. 2007, v. 214, p. 61-67.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Boussault P., Leaute-Labreze C., Saubusse E. et al. Oat sensitization in children with atopic dermatitis : prevalence, risks and associated factors. Allergy. 2007, v. 62, p. 1251-1256.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Rautalahti M., Terho E.O., Vohlonen I., Husman K. Atopic sensitization of dairy farmers to work-related and common allergens. Eur. J. Respir. Dis. 1987, v. 152 (Suppl.), р. 155-164.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Block G., Tse K.S., Kijek K. et al. Baker's asthma. Studies of the cross-antigenicity between different cereal grains. Clin. Allergy. 1984, v. 14, p. 177-185.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Pigatto P., Bigardi A., Caputo R. et al. An evaluation of the allergic contact dermatitis potential of colloidal grain suspensions. Am. J. Contact Dermat. 1997, v. 8, p. 207-209</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Loffler H., Becker D., Brash J. et al. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG). Br. J. Dermatol. 2005, v. 152, p. 709-719.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Benard F., Marty J.P., Nicolas J.F. Allergen penetration through the skin. Eur. J. Dermatol. 2003, v. 13, p. 324-330.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Williams H.C. Clinical practice: atopic dermatitis. N. Engl. J. Med. 2005, v. 352, p. 2314-2324.</mixed-citation></ref></ref-list></back></article>
